A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity	Upper Limb Spasticity	Recruiting	Phase 3	2026-04-02		NCT07478822

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chongqing Claruvis Pharmaceutical Co., Ltd.	2

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Guangdong Provincial People's Hospital	Guangdong	China	5
Huai'an First Hospital Affiliated to Nanjing Medical University	Huai'an	China	1
Peking Union Medical College Hospital	Beijing	China	112
Shanghai Fudan University HuaShan Hospital	Shanghai	China	1
Shanxi Bethune Hospital	Taiyuan	China	11
Shenzhen Second People's Hospital	Shenzhen	China	6
Sun Yat-Sen Memorial Hospital	Guangzhou	China	10
The First Affiliated Hospital of Henan University	Kaifeng	China	1
The First Affiliated Hospital of Soochow University	Suzhou	China	28
The Second Affiliated Hospital of Kunming Medical University	Kunming	China	5
The Second People's Hospital of Hefei	Hefei	China	2
Tianjin Medical University General Hospital	Tianjin	China	28
West China Hospital，Sichuan University	Chengdu	China	1
Xuzhou Medical University Affiliated Hospital	Xuzhou	China	1
Yangzhi Affiliated Rehabilitation Hospital of Tongji University	Shanghai	China	1
Zibo Municipal Hospital	Zibo	China	4